Table 3 Subgroup analysis for the association between PFA and RCC pathological types
From: The relationship between renal cell carcinoma pathological types and perirenal fat area
Model | Pathological stage 2 = T1 | Pathological stage 2 ≥ T2 | Total |
|---|---|---|---|
Tumor location OPLK | |||
Model 1 (OR,95%CI, P) | 1.06 (1.01,1.11) 0.0300 | 1.05 (0.96,1.14) 0.3178 | 1.05 (1.01,1.10) 0.0169 |
Model 2 (OR,95%CI, P) | 1.20 (1.06,1.36) 0.0043 | 1.04 (0.87,1.22) 0.6568 | 1.14 (1.04,1.26) 0.0057 |
Model 3 (OR,95%CI, P) | 1.20 (1.06,1.37) 0.0045 | 1.02 (0.85,1.22) 0.8297 | 1.14 (1.04,1.26) 0.0070 |
Tumor location WPLK | |||
Model 1 (OR,95%CI, P) | 1.03 (0.97,1.10) 0.3359 | 1.00 (0.89,1.13) 0.9933 | 1.02 (0.97,1.08) 0.3793 |
Model 2 (OR,95%CI, P) | 0.95 (0.87,1.05) 0.3147 | 0.00 (0.00, Inf) 0.9987 | 0.98 (0.90,1.07) 0.6677 |
Model 3 (OR,95%CI, P) | 0.95 (0.86,1.05) 0.2998 | Inf. (0.00, Inf) 0.9993 | 0.98 (0.90,1.07) 0.6807 |
Total | |||
Model 1 (OR,95%CI, P) | 1.05 (1.01,1.09) 0.0197 | 1.03 (0.96,1.11) 0.3989 | 1.04 (1.01,1.08) 0.0146 |
Model 2 (OR,95%CI, P) | 1.05 (0.98,1.13) 0.1808 | 1.08 (0.95,1.24) 0.2447 | 1.05 (0.99,1.12) 0.1093 |
Model 3 (OR,95%CI, P) | 1.05 (0.98,1.13) 0.1862 | 1.07 (0.93,1.23) 0.3606 | 1.05 (0.99,1.12) 0.1281 |